---
reference_id: "PMID:31751304"
title: Genetic investigation of patients with tall stature.
authors:
- Vasco de Albuquerque Albuquerque E
- Ferreira de Assis Funari M
- Pereira de Souza Quedas E
- Sayuri Honjo Kawahira R
- Soares Jallad R
- Homma TK
- Martin RM
- Brito VN
- Malaquias AC
- Lerario AM
- Rosenberg C
- Victorino Krepischi AC
- Ae Kim C
- Arnhold IJP
- Jorge AAL
journal: Eur J Endocrinol
year: '2020'
doi: 10.1530/EJE-19-0785
content_type: abstract_only
---

# Genetic investigation of patients with tall stature.
**Authors:** Vasco de Albuquerque Albuquerque E, Ferreira de Assis Funari M, Pereira de Souza Quedas E, Sayuri Honjo Kawahira R, Soares Jallad R, Homma TK, Martin RM, Brito VN, Malaquias AC, Lerario AM, Rosenberg C, Victorino Krepischi AC, Ae Kim C, Arnhold IJP, Jorge AAL
**Journal:** Eur J Endocrinol (2020)
**DOI:** [10.1530/EJE-19-0785](https://doi.org/10.1530/EJE-19-0785)

## Content

1. Eur J Endocrinol. 2020 Feb;182(2):139-147. doi: 10.1530/EJE-19-0785.

Genetic investigation of patients with tall stature.

Vasco de Albuquerque Albuquerque E(1), Ferreira de Assis Funari M(2), Pereira de 
Souza Quedas E(1), Sayuri Honjo Kawahira R(3), Soares Jallad R(4), Homma TK(1), 
Martin RM(2)(5), Brito VN(2), Malaquias AC(1)(6), Lerario AM(1)(7), Rosenberg 
C(8), Victorino Krepischi AC(8), Ae Kim C(3), Arnhold IJP(2), Jorge AAL(1).

Author information:
(1)Unidade de Endocrinologia Genética (LIM25), Laboratório de Hormônios e 
Genética Molecular (LIM42), Hospital das Clínicas da Faculdade de Medicina, 
Universidade de São Paulo (USP), São Paulo, Brasil.
(2)Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e 
Genética Molecular (LIM42), Hospital das Clínicas da Faculdade de Medicina, 
Universidade de São Paulo (USP), São Paulo, Brasil.
(3)Unidade de Genética do Instituto da Criança, Hospital das Clínicas da 
Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brasil.
(4)Unidade de Neuroendocrinologia, Hospital das Clínicas da Faculdade de 
Medicina, Universidade de São Paulo (USP), São Paulo, Brasil.
(5)Unidade de Doenças Osteometabólicas, Hospital das Clínicas da Faculdade de 
Medicina, Universidade de São Paulo (USP), São Paulo, Brasil.
(6)Unidade de Endocrinologia Pediátrica, Departamento de Pediatria, Irmandade da 
Santa Casa de Misericórdia de São Paulo, São Paulo, Brasil.
(7)Division of Metabolism, Endocrinology and Diabetes, Department of Internal 
Medicine, University of Michigan, Ann Arbor, Michigan, USA.
(8)Instituto de Biociências (IB), Universidade de São Paulo (USP), São Paulo, 
Brasil.

CONTEXT: Patients with tall stature often remain undiagnosed after clinical 
investigation and few studies have genetically assessed this group, most of them 
without a systematic approach.
OBJECTIVE: To assess prospectively a group of individuals with tall stature, 
with and without syndromic features, and to establish a molecular diagnosis for 
their growth disorder.
DESIGN: Screening by karyotype (n = 42), chromosome microarray analyses (CMA) (n 
= 16), MS-MLPA (n = 2) targeted panel (n = 12) and whole-exome sequencing (n = 
31).
PATIENTS AND METHODS: We selected 42 patients with tall stature after exclusion 
of pathologies in GH/IGF1 axis and divided them into syndromic (n = 30) and 
non-syndromic (n = 12) subgroups.
MAIN OUTCOME MEASURES: Frequencies of pathogenic findings.
RESULTS: We identified two patients with chromosomal abnormalities including 
SHOX trisomy by karyotype, one 9q22.3 microdeletion syndrome by CMA, two cases 
of Beckwith-Wiedemann syndrome by targeted MS-MLPA analysis and nine cases with 
heterozygous pathogenic or likely pathogenic genetic variants by multigene 
analysis techniques (FBN1 = 3, NSD1 = 2, NFIX = 1, SUZ12 = 1, CHD8 = 1, MC4R = 
1). Three of 20 patients analyzed by WES had their diagnosis established. Only 
one non-syndromic patient had a definitive diagnosis. The sequential genetic 
assessment diagnosed 14 out of 42 (33.3%) tall patients.
CONCLUSION: A systematic molecular approach of patients with tall stature was 
able to identify the etiology in 13 out of 30 (43.3%) syndromic and 1 out of 12 
(8.3%) non-syndromic patients, contributing to the genetic counseling and 
avoiding unfavorable outcomes in the syndromic subgroup.

DOI: 10.1530/EJE-19-0785
PMID: 31751304 [Indexed for MEDLINE]